Autor: "Ciceri F" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia.
Autorzy:: Dholaria B; Department of Hematology-Oncology, Vanderbilt University Medical Center, 220 Pierce Ave, 777 Preston Research Building, Nashville, TN, 37232, USA. .
Labopin M; EBMT ALWP Office, Hôpital Saint-Antoine, Paris, France.
Sanz J; Hematology Department, University Hospital La Fe, Valencia, Spain.
Ruggeri A; Department of Pediatric Hematology and Oncology IRCCS, Ospedale Pediatrico Bambino Gesù, Rome, Italy.
Cornelissen J; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Labussière-Wallet H; Hôpital Lyon Sud, Hospices Civils de Lyon, Pierre Bénite, France.
Blaise D; Programme de Transplantation and Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Forcade E; Hôpital Haut-Leveque, CHU Bordeaux, Pessac, France.
Chevallier P; Department of D'Hematologie, CHU Nantes, Nantes, France.
Grassi A; Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Zubarovskaya L; RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation.
Kuball J; Department of Haematology, University Medical Centre, Utrecht, The Netherlands.
Ceballos P; Département d'Hématologie Clinique, CHU Lapeyronie, Montpellier, France.
Ciceri F; Ospedale San Raffaele S.R.L., Haematology and BMT, Milan, Italy.
Baron F; CHU and University of Liège, Liège, Belgium.
Savani BN; Department of Hematology-Oncology, Vanderbilt University Medical Center, 220 Pierce Ave, 777 Preston Research Building, Nashville, TN, 37232, USA.
Nagler A; Chaim Sheba Medical Center, Tel Hashomer, Israel.; ALWP Office Hôpital Saint-Antoine, Paris, France.
Mohty M; EBMT ALWP Office, Hôpital Saint-Antoine, Paris, France.; Service d'Hématologie Clinique et Thérapie Cellulaire, Hôpital Saint-Antoine, UMRs 938, AP-HP, Sorbonne University, and INSERM, Paris, France.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2021 May 03; Vol. 14 (1), pp. 76. Date of Electronic Publication: 2021 May 03.
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Cord Blood Stem Cell Transplantation/*methods
Cyclophosphamide/*therapeutic use
Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid, Acute/*drug therapy
Transplantation Conditioning/*methods
Adolescent ; Adult ; Aged ; Cyclophosphamide/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Unrelated Donors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Unmanipulated haploidentical in comparison with matched unrelated donor stem cell transplantation in patients 60 years and older with acute myeloid leukemia: a comparative study on behalf of the ALWP of the EBMT.
Autorzy:: Santoro N; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France. .; Section of Hematology, Department of Medicine, University of Perugia, Centro Ricerche Emato-Oncologiche (CREO), Perugia, Italy. .
Labopin M; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.; ALWP office, Hôpital Saint-Antoine, Paris, France.
Giannotti F; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.
Ehninger G; Medical Clinic and Policlinic I, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Niederwieser D; Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany.
Brecht A; Center for Blood Stem Cell and Bone Marrow Transplant, DKD Helios Clinic Wiesbaden, Wiesbaden, Germany.
Stelljes M; Department of Medicine A/Hematology and Oncology, University of Muenster, Muenster, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Einsele H; Department of Internal Medicine II, University Hospital Wurzburg, Würzburg, Germany.
Eder M; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
Hallek M; Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University Hospital of Cologne, Cologne, Germany.
Glass B; Department of Hematology and Oncology, Asklepios Klinik St. Georg Hamburg, Hamburg, Germany.
Finke J; Department of Medicine-Hematology, Oncology, University of Freiburg, Freiburg, Germany.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Mohty M; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.
Ruggeri A; Department of Hematology and Cell Therapy, Saint-Antoine Hospital, Paris, France.; Department of Pediatric Hematology and Oncology, IRCCS Bambino Gesù Children's Hospital, Piazza S Onofrio, 4, 00165, Rome, Italy.
Nagler A; ALWP office, Hôpital Saint-Antoine, Paris, France.; Department of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2018 Apr 16; Vol. 11 (1), pp. 55. Date of Electronic Publication: 2018 Apr 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid, Acute/*therapy
Transplantation Conditioning/*methods
Aged ; Aged, 80 and over ; Female ; Humans ; Leukemia, Myeloid, Acute/pathology ; Male ; Retrospective Studies ; Unrelated Donors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.
Autorzy:: Rubio MT; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France. mt_.; INSERM UMR 938, Paris, France. mt_.; Université Pierre et Marie Curie, Paris, France. mt_.; Acute Leukemia Working Party of EBMT, Paris, France. mt_.
Savani BN; Acute Leukemia Working Party of EBMT, Paris, France.; Vanderbilt University Medical Center, Nashville, TN, USA.
Labopin M; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Piemontese S; Acute Leukemia Working Party of EBMT, Paris, France.; Ospedale San Raffaele s.r.l., Ematologia, Milan, Italy.
Polge E; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Ciceri F; Ospedale San Raffaele s.r.l., Ematologia, Milan, Italy.
Bacigalupo A; Department of Haematology II, Ospedale San Martino, Genoa, Italy.
Arcese W; Rome Transplant Network, Stem Cell Transplant Unit, Tor Vergata University, Rome, Italy.
Koc Y; Stem Cell Transplant Unit, Medical Park Hospitals, Antalya, Turkey.
Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Gülbas Z; Bone Marrow Transplantation Department, Anadolu Medical Center Hospital, Kocaeli, Turkey.
Wu D; Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China.
Santarone S; Ospedale Civile BMT Center, Pescara, Italy.
Tischer J; Department of Internal Medicine III, Ludwig-Maximilians-University Hospital of Munich-Grosshadern, Munich, Germany.
Afanasyev B; SPb State I. Pavlov Medical University, St. Petersburg, Russia.
Schmid C; Klinikum Augsburg, University of Munich, Munich, Germany.
Giebel S; Department of Bone Marrow Transplantation and Hemato-Oncology, Cancer Center, Gliwice, Poland.
Mohty M; Service d'Hématologie et de Thérapie cellulaire, Saint Antoine Hospital, Paris, France.; INSERM UMR 938, Paris, France.; Université Pierre et Marie Curie, Paris, France.; Acute Leukemia Working Party of EBMT, Paris, France.; EBMT Paris study office/CEREST-TC, Paris, France.
Nagler A; Université Pierre et Marie Curie, Paris, France.; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.; Pokaż więcej
Źródło:: Journal of hematology & oncology [J Hematol Oncol] 2016 Mar 15; Vol. 9, pp. 25. Date of Electronic Publication: 2016 Mar 15.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Hematopoietic Stem Cell Transplantation/*methods
Leukemia, Myeloid/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Transplantation Conditioning/*methods
Acute Disease ; Adult ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclophosphamide/administration & dosage ; Cytarabine/administration & dosage ; Disease-Free Survival ; Female ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Melphalan/administration & dosage ; Middle Aged ; Multivariate Analysis ; Mycophenolic Acid/administration & dosage ; Mycophenolic Acid/analogs & derivatives ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Conditioning intensity in middle-aged patients with AML in first CR: no advantage for myeloablative regimens irrespective of the risk group-an observational analysis by the Acute Leukemia Working Party of the EBMT.
Autorzy:: Passweg JR; Division of Hematology, University Hospital Basel, Basel, Switzerland.
Labopin M; EBMT Paris Study Office, Paris, France.
Cornelissen J; Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, The Netherlands.
Volin L; Stem Cell Transplantation Unit, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Socié G; Division of Hematology, Hospital St Louis & University Paris, Paris, France.
Huynh A; CHU Department Hematologie, Hopital de Purpan, Toulouse, France.
Tabrizi R; CHU Bordeaux, Hôpital Haut-leveque, Pessac, France.
Wu D; Department of Hematology, First Affiliated Hospital of Soochow University, Suzhou, China.
Craddock C; Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, UK.
Schaap N; Department of Hematology, Nijmegen Medical Centre, Radboud University, Nijmegen, The Netherlands.
Kuball J; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
Chevallier P; Department D'Hematologie, CHU Nantes, Nantes, France.
Cahn JY; Clinique Universitaire d'Hématologie CHU Grenoble, Grenoble, France.
Blaise D; Département D'Onco-Hématologie, Institut Paoli Calmettes, Marseille, France.
Ghavamzadeh A; Hematology-Oncology and BMT Research, Shariati Hospital, Teheran, Iran.
Bilger K; CHU Hautepierre-Service d'Onco Hematologie, Strasbourg, France.
Ciceri F; Ospedale San Raffaele, Milano, Italy.
Schmid C; Medizinische Klinik II, Klinikum Augsburg, Augsburg, Germany.
Giebel S; Department of Bone Marrow Transplantation and Hematology-Oncology, Maria Sklodowska-Curie Memorial Cancer Center, Gliwice, Poland.
Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Mohty M; Department of Hematology, Hospital Saint Antoine, Paris, France.; Pokaż więcej
Corporate Authors:: Acute Leukemia Working Party of the European Blood and Marrow Transplant Group (EBMT)
Źródło:: Bone marrow transplantation [Bone Marrow Transplant] 2015 Aug; Vol. 50 (8), pp. 1063-8. Date of Electronic Publication: 2015 Jun 01.
Typ publikacji:: Clinical Trial; Journal Article; Multicenter Study; Observational Study
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute/*mortality
Leukemia, Myeloid, Acute/*therapy
Transplantation Conditioning/*methods
Adult ; Allografts ; Disease-Free Survival ; Female ; Humans ; Male ; Middle Aged ; Risk Factors ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Experts' considerations on HLA-haploidentical stem cell transplantation.
Autorzy:: Patriarca F; Department of Hematology, Stem Cell Transplant Unit, DISM, University Hospital, Udine, Italy.
Luznik L
Medeot M
Zecca M
Bacigalupo A
Di Bartolomeo P
Arcese W
Corradini P
Ciceri F
Vago L
Kanakry CG
Fleischhauer K
Martelli MF
Bosi A
Rambaldi A
Cesaro S
Russo D
Fanin R; Pokaż więcej
Źródło:: European journal of haematology [Eur J Haematol] 2014 Sep; Vol. 93 (3), pp. 187-97. Date of Electronic Publication: 2014 Apr 26.
Typ publikacji:: Journal Article
MeSH Terms:: Hematopoietic Stem Cell Transplantation*
Transplantation Conditioning*
Graft vs Host Disease/*prevention & control
HLA Antigens/*immunology
Hematologic Neoplasms/*therapy
Immunosuppressive Agents/*therapeutic use
Myeloablative Agonists/*therapeutic use
ABO Blood-Group System/immunology ; Congresses as Topic ; Cytomegalovirus Infections/diagnosis ; Graft vs Host Disease/immunology ; Graft vs Host Disease/pathology ; Hematologic Neoplasms/immunology ; Hematologic Neoplasms/pathology ; Histocompatibility ; Histocompatibility Testing ; Humans ; Immunotherapy, Adoptive ; Lymphocyte Depletion ; Patient Selection ; Time Factors ; Transplantation, Homologous ; Unrelated Donors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
Autorzy:: Fleischhauer K; 1] Institute of Experimental Cellular Therapy, Essen University Hospital, Essen, Germany [2] Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute, Milan, Italy.
Fernandez-Viña MA; Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford University Medical School, Stanford, CA, USA.
Wang T; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Haagenson M; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Battiwalla M; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Baxter-Lowe LA; Immunogentics and Transplantation Lab, University of California San Francisco Medical Center, San Francisco, CA, USA.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Dehn J; National Marrow Donor Program, Minneapolis, MN, USA.
Gajewski J; Oregon Health and Science University, Portland, OR, USA.
Hale GA; Pediatric Hematology/Oncology/BMT, All Children's Hospital, St Petersburg, FL, USA.
Heemskerk MB; Dutch Transplant Foundation, Leiden, The Netherlands.
Marino SR; Department of Pathology, University of Chicago Hospitals, Chicago, IL, USA.
McCarthy PL; Blood and Marrow Transplant, Roswell Park Cancer Institute, Buffalo, NY, USA.
Miklos D; Department of Medicine/Bone Marrow Transplant, Stanford Hospitals and Clinics, Stanford, CA, USA.
Oudshoorn M; Europdonor Foundation, Leiden University Medical Center, Leiden, Netherlands.
Pollack MS; Department of Pathology, University of Texas Health Care System, San Antonio, TX, USA.
Reddy V; Department of Hemaotology/Oncology, University of Florida, Gainesville, FL, USA.
Senitzer D; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA, USA.
Shaw BE; Anthony Nolan Research Institute, London, UK.
Waller EK; Bone Marrow and Stem Cell Transplant Center, Emory University Hospital, Atlanta, GA, USA.
Lee SJ; Clinical Transplant Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Spellman SR; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.; Pokaż więcej
Źródło:: Bone marrow transplantation [Bone Marrow Transplant] 2014 Sep; Vol. 49 (9), pp. 1176-83. Date of Electronic Publication: 2014 Jun 23.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Epitopes, T-Lymphocyte/*immunology
HLA-DP alpha-Chains/*immunology
HLA-DP beta-Chains/*immunology
Hematopoietic Stem Cell Transplantation/*methods
Transplantation Conditioning/*methods
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Epitope Mapping ; Female ; Humans ; Infant ; Male ; Middle Aged ; Risk ; Unrelated Donors ; Young Adult